Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0000899243-16-027302

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Tasse Daniel · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-08-15 Grant or award : show line 1 in the form Stock Option (Right to Buy) +25,000 $12.30 2026-08-15 25,000 25,000 D
Loading xslF345X03/doc4.xml…